{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:45:07Z","timestamp":1758811507148},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2020,7,14]]},"DOI":"10.1001\/jama.2020.11401","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T15:32:10Z","timestamp":1592580730000},"page":"177","source":"Crossref","is-referenced-by-count":12,"title":["Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19"],"prefix":"10.1001","volume":"324","author":[{"given":"Gregory","family":"Curfman","sequence":"first","affiliation":[{"name":"Deputy Editor, JAMA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"2","key":"jen200006r1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"jen200006r2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bcp.2017.07.022","article-title":"Azilsartan ameliorates diabetic cardiomyopathy in young db\/db mice through the modulation of ACE-2\/ANG 1-7\/Mas receptor cascade.","volume":"144","author":"Sukumaran","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"jen200006r3","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality.","author":"Fosb\u00f8l","journal-title":"JAMA"},{"key":"jen200006r4","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19).","author":"Mehta","journal-title":"JAMA Cardiol"},{"issue":"18","key":"jen200006r5","first-page":"1769","article-title":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?","volume":"323","author":"Patel","year":"2020","journal-title":"JAMA"},{"key":"jen200006r6","article-title":"Renin\u2014angiotensin\u2014aldosterone blockers and the risk of COVID-19.","author":"Mancia","journal-title":"N Engl J Med"},{"key":"jen200006r7","article-title":"Renin\u2014angiotensin\u2014aldosterone inhibitors and risk of COVID-19.","author":"Reynolds","journal-title":"N Engl J Med"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2767668\/jama_curfman_2020_en_200006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T15:26:49Z","timestamp":1594740409000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2767668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,7,14]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.11401","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,14]]}}}